Literature DB >> 24376024

CGTase-catalysed cis-glucosylation of L-rhamnosides for the preparation of Shigella flexneri 2a and 3a haptens.

Carole Urbach1, Sami Halila, Catherine Guerreiro, Hugues Driguez, Laurence A Mulard, Sylvie Armand.   

Abstract

We report the enzymatic synthesis of α-D-glucopyranosyl-(1→4)-α-L-rhamnopyranoside and α-D-glucopyranosyl-(1→3)-α-L-rhamnopyranoside by using a wild-type transglucosidase in combination with glucoamylase and glucose oxidase. It was shown that Bacillus circulans 251 cyclodextrin glucanotransferase (CGTase, EC 2.1.4.19) can efficiently couple an α-L-rhamnosyl acceptor to a maltodextrin molecule with an α-(1→4) linkage, albeit in mixture with the α-(1→3) regioisomer, thus giving two glucosylated acceptors in a single reaction. Optimisation of the CGTase coupling reaction with β-cyclodextrin as the donor substrate and methyl or allyl α-L-rhamnopyranoside as acceptors resulted in good conversion yields (42-70%) with adjustable glycosylation regioselectivity. Moreover, the efficient chemical conversion of the products of CGTase-mediated cis-glucosylation into protected building blocks (previously used in the synthesis of O-antigen fragments of several Shigella flexneri serotypes) was substantiated. These novel chemoenzymatic strategies towards useful, convenient intermediates in the synthesis of S. flexneri serotypes 2a and 3a oligosaccharides might find applications in developments towards synthetic carbohydrate-based vaccine candidates against bacillary dysentery.
Copyright © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Shigella flexneri; biocatalysis; carbohydrates; cis-glycosylation; cyclodextrin glucanotransferase

Mesh:

Substances:

Year:  2013        PMID: 24376024     DOI: 10.1002/cbic.201300597

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  1 in total

Review 1.  Comprehensive study on transglycosylation of CGTase from various sources.

Authors:  Chin Hui Lim; Babak Rasti; Joko Sulistyo; Mansoor Abdul Hamid
Journal:  Heliyon       Date:  2021-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.